Cancer Immunology & Prevention

ICI trial for adults with cancers from pediatric cancer therapy

Immune checkpoint inhibitors (ICIs) works against cancers with many somatic mutations, because immune systems recognizes these as "non-self" antigens. ICI therapy is proposed for former pediatric cancer patients with therapy-induced late cancers.

Voting

0 votes
Ideate
Idea No. 616

Attachments

- [ Show all ]